Vital Farms (VITL) to Release Quarterly Earnings on Thursday

Vital Farms (NASDAQ:VITL) is projected to post its Q4 2025 results before the market opens on Thursday, February 26th. Analysts expect Vital Farms to post earnings of $0.38 per share and revenue of $212.8260 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 26, 2026 at 8:30 AM ET.

Vital Farms Stock Up 0.7%

Vital Farms stock opened at $25.76 on Wednesday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.15 and a current ratio of 2.65. Vital Farms has a one year low of $25.42 and a one year high of $53.13. The company has a 50-day simple moving average of $29.20 and a 200-day simple moving average of $36.48. The firm has a market capitalization of $1.15 billion, a P/E ratio of 19.52 and a beta of 1.10.

Analysts Set New Price Targets

Several research analysts have commented on VITL shares. Morgan Stanley decreased their target price on shares of Vital Farms from $48.00 to $45.00 and set an “overweight” rating for the company in a research report on Wednesday, December 17th. Mizuho dropped their target price on Vital Farms from $53.00 to $48.00 and set an “outperform” rating on the stock in a report on Wednesday, November 26th. Benchmark restated a “buy” rating on shares of Vital Farms in a research report on Wednesday, January 14th. Jefferies Financial Group reiterated a “buy” rating and set a $52.00 price target on shares of Vital Farms in a research report on Wednesday, December 17th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Vital Farms in a research note on Monday, December 29th. Twelve research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $49.91.

Insider Activity at Vital Farms

In other news, insider Matthew Ohayer sold 25,000 shares of the business’s stock in a transaction on Friday, January 2nd. The stock was sold at an average price of $30.85, for a total transaction of $771,250.00. Following the sale, the insider directly owned 6,361,190 shares of the company’s stock, valued at $196,242,711.50. The trade was a 0.39% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Russell Diez-Canseco sold 16,734 shares of the company’s stock in a transaction on Monday, December 15th. The shares were sold at an average price of $35.05, for a total value of $586,526.70. Following the sale, the chief executive officer directly owned 649,684 shares of the company’s stock, valued at approximately $22,771,424.20. This represents a 2.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 91,734 shares of company stock worth $2,921,477. 21.30% of the stock is currently owned by company insiders.

Institutional Trading of Vital Farms

A number of hedge funds have recently bought and sold shares of VITL. Royal Bank of Canada raised its stake in shares of Vital Farms by 89.2% during the 1st quarter. Royal Bank of Canada now owns 19,381 shares of the company’s stock worth $591,000 after purchasing an additional 9,136 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Vital Farms by 5.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company’s stock worth $611,000 after buying an additional 1,108 shares during the last quarter. Goldman Sachs Group Inc. raised its position in Vital Farms by 3.3% during the first quarter. Goldman Sachs Group Inc. now owns 415,420 shares of the company’s stock valued at $12,658,000 after acquiring an additional 13,397 shares in the last quarter. Woodline Partners LP acquired a new stake in Vital Farms in the first quarter valued at approximately $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Vital Farms by 1.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company’s stock valued at $2,739,000 after acquiring an additional 1,198 shares during the last quarter. 98.59% of the stock is owned by hedge funds and other institutional investors.

Vital Farms Company Profile

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.